期刊文献+

2型糖尿病患者超声定量肝脏脂肪含量的临床意义 被引量:2

Clinical value of ultrasonic quantitative detection of liver fat content in patients with type 2 diabetes mellitusl
原文传递
导出
摘要 目的 分析超声定量检测T2DM患者肝脏脂肪含量(LFC)和各临床资料及血脂组分的相关性. 方法 采用超声定量检测306例住院T2DM患者LFC,分别记录性别、年龄、体重、BMI、WC、臀围(HC)、WHR及病程等临床资料,并检测TC、TG、HDL-C、LDL-C,根据LFC三分位分为Q1~Q3组,分析其与各临床资料及血脂组分的相关性. 结果 随LFC增加,各组体重、BMI、WC、HC、WHR、TG均逐步增加,而年龄和病程逐步递减(P<0.05).校正性别、年龄、BMI后,偏相关分析显示,LFC与TG呈线性正相关(r=0.216,P=0.000). 结论 T2DM患者超声定量检测LFC对非酒精性脂肪性肝病诊治有一定的临床应用价值,其与体重、BMI、WC、HC、WHR有关,与血清TG水平呈正相关. Objective To analyze the relation of ultrasonic quantitative detection of live fat content(LFC) with clinical data and blood lipid components in patients with type 2 diabetes mellitus.Methods Ultrasonic quantitative detection of LFC was performed in 306 hospitalized patients with T2DM,and gender,age,weight,BMI,waist circumference,hip circumference,waist-to-hip ratio and course were recorded.The serum level of TC,TG,HDL-C,LDL-C were detected.All subjects were divided into Q1~ Q3 groups according to tertiles of LFC.Correlation of LFC with clinical data and blood lipid composition were analyzed among three groups.Results With the increase of LFC,index such as body weight,BMI,waist circumference,hip circumference,waist-to-hip ratio,TG were gradually increased,while age and course of the disease were gradually decreased (P〈0.05).After adjusting for gender,age and BMI,partial correlation analysis showed that LFC was positively associated with TG(r=0.216,P =0.000).Conclusion In patients with T2DM,Ultrasonic quantitative detection of LFC has higher clinical value to diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD),and it is correlated with weight,BMI,waist circumference,hip circumference and waist-to-hip ratio.Besides,LFC is obviously positively correlated with TG.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2014年第11期966-969,共4页 Chinese Journal of Diabetes
关键词 糖尿病 2型 超声 肝脏脂肪含量 Diabetes mellitus, type 2 Ultrasound Liver fat content
  • 相关文献

参考文献2

二级参考文献34

  • 1[1]Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology 2003; 37:1202-1219
  • 2[2]Bellentani S,Saccoccio G,Masutti F,Croce LS,Brandi G,Sasso F,Cristanini G,Tiribelli C.Prevalence of and risk factors for hepatic steatosis in Northern Italy.Ann Intern Med 2000;132:112-117
  • 3[3]Browning JD,Szczepaniak LS,Dobbins R,Nuremberg P,Morton JD,Cohen JC,Grundy SM,Hobbs HH.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity.Hepatology 2004; 40:1387-1395
  • 4[4]Chitturi S,Farrell GC,George J.Non-alcoholic steatohepatitis in the Asia-Pacific region:future shock? J Gastroenterol Hepatol 2004; 19:368-374
  • 5[5]Akbar DH,Kawther AH.Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic:prevalence and general characteristics.Diabetes Care 2003; 26:3351-3352
  • 6[6]Gupte P,Amarapurkar D,Agal S,Baijal R,Kulshrestha P,Pramanik S,Patel N,Madan A,Amarapurkar A,Hafeezunnisa.Non-alcoholic steatohepatitis in type 2 diabetes mellitus.J Gastroenterol Hepatol 2004; 19:854-858
  • 7[7]Assy N,Kaita K,Mymin D,Levy C,Rosser B,Minuk G.Fatty infiltration of liver in hyperlipidemic patients.Dig Dis Sci 2000; 45:1929-1934
  • 8[8]Donati G,Stagni B,Piscaglia F,Venturoli N,Morselli-Labate AM,Rasciti L,Bolondi L.Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes:role of insulin resistance.Gut 2004; 53:1020-1023
  • 9[9]Hamaguchi M,Kojima T,Takeda N,Nakagawa T,Taniguchi H,Fujii K,Omatsu T,Nakajima T,Sarui H,Shimazaki M,Kato T,Okuda J,Ida K.The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.Ann Intern Med 2005; 143:722-778
  • 10[10]Isomaa B,Almgren P,Tuomi T,Forsen B,Lahti K,Nissen M,Taskinen MR,Groop L.Cardiovascular morbidity and mortality associated with the metabolic syndrome.Diabetes Care 2001; 24:683-689

共引文献71

同被引文献7

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部